FSHR and ovarian carcinoma: The evaluations carried out on ovarian cancer cells demonstrated the relevance of miR-145 incorporation on a nanosystem structured to achieve better delivery into ovarian cancer cells, taking advantage of the specific presence of FSHR in these types of cells.